The current state of metabolic health in the United States and most westernized countries has sparked a great interest in a GLP1 agonist, AKA Semaglutide Ozempic. So I wanted to talk to a clinician actively utilizing this medication.

Dr. Gapin and I discuss what this drug class represents. (These are synthetic peptides.) We speak about Semaglutide, Ozempic, Wegovy, and oral Rybelsus. We get into current research, side effects, who should not take these medications, and the mechanisms of action specific to the pancreas and beta cells, reductions, gastric emptying, and the upregulation of satiety. We discuss changes in the brain regarding leptin and how these drugs work. We also talk about weight loss resistance, and I answer questions from listeners.

From my perspective, it all comes back to basics. I believe that if we are to prescribe these medications, we must help our patients understand how lifestyle impacts weight-loss resistance and metabolic health. I loved that Dr. Tracy spent some time talking about the specific ways he works with his patients, even before prescribing medications. He also explains how important he has felt this drug has been for his patients.

I approached today’s conversation with an open mind, and I hope you will do the same.

IN THIS EPISODE YOU WILL LEARN:

How the GLP1 agonists help Dr. Tracy motivate his patients to lose weight.
What are GLP1 agonists, and how do they work?
The physical benefits of GLP1 agonists.
Who is Semaglutide not appropriate for?
Some of the common side-effects of GLP1 agonists.
How those who fail to implement lifestyle changes when they stop using Semaglutide may regain all the weight they lost.
Why it is essential to stay hydrated when using Semaglutide.
Why you need to eat enough food- protein in particular when taking Semaglutide.
How to follow the metrics that matter.
Some factors that could hinder successful weight loss.
What Dr. Tracy does to ensure his patients do not regain the weight they lost after they stop using Semaglutide.

Listener questions:

Why is a diabetic drug being used for non-diabetics?
Does this drug target muscle versus fat in terms of weight loss?
For how long do most patients take it?
Are there unique characteristics in perimenopausal and menopausal women that must be accounted for differently?

Bio:

Dr. Tracy Gapin is a board-certified urologist, a world-renowned men’s health & performance expert, and the founder of the Gapin Institute, the global leader in High-Performance Health.

He has over 20 years of experience focused on men’s health optimization, human performance, and longevity, providing executives & entrepreneurs a personalized path to fulfill their highest potential. He’s been featured in Entrepreneur, Dave Asprey’s Biohacking Conference, and as a TEDx speaker.

Connect with Cynthia Thurlow

Follow on Twitter, Instagram & LinkedIn

Check out Cynthia’s website

Connect with Tracy Gapin

On his website

Gapin Institute

Text “Health” to 26786 to receive 10 Secrets to High-Performance Health and a free copy of Dr. Gapin’s book.